Role of nitric oxide in diabetes-induced attenuation of antinociceptive effect of morphine in mice
- 5 July 2000
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 399 (2-3) , 161-164
- https://doi.org/10.1016/s0014-2999(00)00343-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Inhibition of Constitutive and Inducible Nitric Oxide Synthase: Potential Selective InhibitionAnnual Review of Pharmacology and Toxicology, 1995
- Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in miceNeuropharmacology, 1994
- Serum glucose level-dependent and independent modulation of μ-opioid agonist-mediated analgesia in diabetic miceLife Sciences, 1993
- Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cordLife Sciences, 1993
- Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide.Circulation Research, 1993
- Nitric Oxide Production from Macrophages Is Regulated by Arachidonic Acid MetabolitesBiochemical and Biophysical Research Communications, 1993
- The effects of cyclosporine on morphine-induced antinociception in diabetic miceNeuroscience Letters, 1993
- Selective inhibition of the inducible nitric oxide synthase by aminoguanidineEuropean Journal of Pharmacology, 1993
- NG-Nitro-L-arginine prevents morphine toleranceEuropean Journal of Pharmacology, 1992
- Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ- and κ-opioid agonistsBrain Research, 1992